Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Harshada Rambaboo Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Indolizines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Series of 7‐(Trifluoromethyl) substituted indolizine 4a‐g was synthesized using the one‐pot method. Spectroscopic techniques such as IR, 1 H‐NMR, 13 C‐NMR, and HRMS were used for the structure confirmation of newly synthesized compounds. These 4a‐g compounds were tested for their anti‐inflammatory activity. In this study, we identified novel indolizine derivative compounds 4a‐g selectively targeting COX‐2 enzyme, tumor necrosis factor‐α (TNF‐α) and, interleukin‐6 (IL‐6). The in silico docking studies of 4a‐g showed that these compounds have a higher affinity for COX‐2 enzyme, TNF‐ α, and IL‐6. In silico ADME profile analysis predicts that these compounds have good gastrointestinal tract and blood–brain barrier absorption. In vitro studies showed that compound 4d significantly reduces the level of COX‐2 enzymes as compared to indomethacin. Compounds 4e , 4f , and 4a were also found to significantly reduce the level of TNF‐α, while compounds 4f , 4g , and 4d , showed a reduction in the level of IL‐6 when compared to indomethacin. Compounds 4a , 4d , and 4f also reduces nitric oxide (NO) level, compared to indomethacin. Overall, the current study illustrates significant anti‐inflammatory activities of these novel 7‐(Trifluoromethyl) substituted indolizine derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India.
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research Raebareli, Transit Campus, Lucknow, India.
ORCID-Profile: Sandeep Chandrashekharappa
Zitieren
APA
Singh, H. R., Kushwaha, P., Tandon, R., Srivastava, N., & Chandrashekharappa, S. (2024). Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14514
Vancouver
Singh HR, Kushwaha P, Tandon R, Srivastava N, Chandrashekharappa S. Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14514
BibTeX
@article{Singh2024,
author = {Singh, Harshada Rambaboo and Kushwaha, Prajjwal and Tandon, Reetika and Srivastava, Nidhi and Chandrashekharappa, Sandeep},
title = {Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14514}
}
EUVIMED